Bulletin n°134

Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease

JAMA Network Open, 2024

Beyond Boundaries in ERBB2-Positive Brain Metastatic Breast Cancer

JAMA Network Open, 2024

Smoking and Melanoma Outcomes—Another Reason to Quit

JAMA Network Open, 2024

Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous Melanoma

JAMA Network Open, 2024

The Evolving Landscape of Hepatocellular Carcinoma Mortality in the US

JAMA Network Open, 2023

Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040

JAMA Network Open, 2023

The new GLOBOCAN methods papers demonstrates global inequalities in data sources

International Journal of Cancer, 2023

The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide

International Journal of Cancer, 2023

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

Journal of the National Cancer Institute, 2022

Treating the Whole Patient With Cancer: The Critical Importance of Understanding and Addressing the Trajectory of Medical Financial Hardship

Journal of the National Cancer Institute, 2022

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial

The Lancet Oncology, 2021

Spinal stereotactic radiotherapy for painful spinal metastasis

The Lancet Oncology, 2021

Raising the Dose and Raising the Cost : The Case of Pembrolizumab in Lung Cancer

2017

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer

2017

Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of Clinical Oncology, 2016

Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation

Journal of Clinical Oncology, 2016

Association of preoperative risk factors with malignancy in pancreatic mucinous cystic neoplasms : A multicenter study

JAMA Surgery, 2016

Mucinous cystic neoplasms of the pancreas : A surgical disease

JAMA Surgery, 2016

Cancer-related PTS linked to very limited cognitive impairment among newly diagnosed BC patients

Journal of the National Cancer Institute, 2015

Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress

Journal of the National Cancer Institute, 2015

Can Money Really Be No Object When Cancer Care Is the Subject?

Journal of Clinical Oncology, 2015

First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis

Journal of Clinical Oncology, 2015

Attenuating pain flare: a new role for an old therapy?

The Lancet Oncology, 2015

Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial

The Lancet Oncology, 2015

Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography

Journal of the National Cancer Institute, 2014

Digital Mammography

Journal of the National Cancer Institute, 2014

Leukaemia and lymphoma: why has survival improved?

The Lancet Oncology, 2014

Physician variation in management of low-risk prostate cancer : A population-based cohort study

JAMA Internal Medicine, 2014

FIfteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

JAMA Internal Medicine, 2014

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

The Lancet Oncology, 2014

Measuring the effectiveness of androgen-deprivation therapy for prostate cancer in the medicare population: Adequate data are neither the same as nor the enemy of perfect data

JAMA Internal Medicine, 2014

HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

The Lancet Oncology, 2014

Global burden of human papillomavirus-positive head and neck cancers

The Lancet Oncology, 2014

Global burden of cancer attributable to high body-mass index in 2012: a population-based study

The Lancet Oncology, 2014

Cancer and high body-mass index: global burden, global effort?

The Lancet Oncology, 2014

Randomized Controlled Trial of a Structured Intervention to Facilitate End-of-Life Decision Making in Patients With Advanced Cancer

Journal of Clinical Oncology, 2013

End-of-Life Care Discussions in Patients With Advanced Cancer

Journal of Clinical Oncology, 2013

Primary Prophylaxis With Hematopoietic Colony Stimulating Factor : Insights From a Canadian Cost-Effectiveness Analysis

Journal of the National Cancer Institute, 2013

Cost-Effectiveness of Filgrastim And Pegfilgrastim as Primary Prophylaxis Against Febrile Neutropenia in Lymphoma Patients

Journal of the National Cancer Institute, 2013

Inequalities in Human Papillomavirus (HPV)–Associated Cancers: Implications for the Success of HPV Vaccination

Journal of the National Cancer Institute, 2013

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

Journal of the National Cancer Institute, 2013

HPV Associated Cancer Incidence Rates Point to Needed Efforts to Increase HPV Vaccination Coverage Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

Journal of the National Cancer Institute, 2013

Health in Europe?successes, failures, and new challenges

The Lancet, 2013

The unequal health of Europeans: successes and failures of policies

The Lancet, 2013

Ageing in the European Union

The Lancet, 2013

Migration and health in an increasingly diverse Europe

The Lancet, 2013

Health and health systems in the Commonwealth of Independent States

The Lancet, 2013

Arm lymphoedema after breast cancer

The Lancet Oncology, 2013

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis

The Lancet Oncology, 2013

Health law and policy in the European Union

The Lancet, 2013